Related Experiment Video
Updated: Nov 10, 2025

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
A KRAS-responsive long non-coding RNA controls microRNA processing
Lei Shi1,2, Peter Magee1,2, Matteo Fassan3
1Transcriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Abstract:
Wild-type KRAS (KRASWT) amplification has been shown to be a secondary means of KRAS activation in cancer and associated with poor survival. Nevertheless, the precise role of KRASWT overexpression in lung cancer progression is largely unexplored. Here, we identify and characterize a KRAS-responsive lncRNA, KIMAT1 (ENSG00000228709) and show that it correlates with KRAS levels both in cell lines and in lung cancer specimens. Mechanistically, KIMAT1 is a MYC target and drives lung tumorigenesis by promoting the processing of oncogenic microRNAs (miRNAs) through DHX9 and NPM1 stabilization while halting the biogenesis of miRNAs with tumor suppressor function via MYC-dependent silencing of p21, a component of the Microprocessor Complex. KIMAT1 knockdown suppresses not only KRAS expression but also KRAS downstream signaling, thereby arresting lung cancer growth in vitro and in vivo. Taken together, this study uncovers a role for KIMAT1 in maintaining a positive feedback loop that sustains KRAS signaling during lung cancer progression and provides a proof of principle that interfering with KIMAT1 could be a strategy to hamper KRAS-induced tumorigenesis.
Insights
Wild-type KRAS (KRASWT) amplification drives lung cancer. Researchers found KIMAT1, a KRAS-responsive lncRNA, promotes tumorigenesis by regulating microRNAs, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Wild-type KRAS (KRASWT) amplification is linked to poor survival in cancer.
- The role of KRASWT overexpression in lung cancer progression remains unclear.
Purpose of the Study:
- To identify and characterize a KRAS-responsive long non-coding RNA (lncRNA) in lung cancer.
- To elucidate the mechanism by which this lncRNA influences lung tumorigenesis.
Main Methods:
- Correlation analysis of KIMAT1 and KRAS levels in cell lines and patient specimens.
- Investigated KIMAT1's role in microRNA processing and biogenesis.
- Assessed the impact of KIMAT1 knockdown on KRAS signaling and tumor growth in vitro and in vivo.
Main Results:
- Identified KIMAT1 (ENSG00000228709) as a KRAS-responsive lncRNA correlating with KRAS levels.
- KIMAT1, a MYC target, stabilizes DHX9 and NPM1 to promote oncogenic miRNA processing.
- KIMAT1 silences p21, halting tumor suppressor miRNA biogenesis, and KRAS downstream signaling.
Conclusions:
- KIMAT1 sustains KRAS signaling through a positive feedback loop in lung cancer progression.
- KIMAT1 knockdown inhibits KRAS expression and downstream signaling, arresting tumor growth.
- Targeting KIMAT1 presents a potential strategy to combat KRAS-driven lung tumorigenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
RNA Performs Diverse...

